(Q34216532)

English

Spironolactone use and higher hospital readmission for Medicare beneficiaries with heart failure, left ventricular ejection fraction <45%, and estimated glomerular filtration rate <45 ml/min/1.73 m(2.).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

Spironolactone use and higher hospital readmission for Medicare beneficiaries with heart failure, left ventricular ejection fraction <45%, and estimated glomerular filtration rate <45 ml/min/1.73 m(2.). (English)

1 reference

Europe PubMed Central

31 July 2017

1 reference

based on heuristic

inferred from title

ejection fraction

1 reference

based on heuristic

inferred from title

object named as

Charity J Morgan

3

0 references

object named as

Ali Ahmed

12

0 references

object named as

Paul W Sanders

6

0 references

Richard M Allman

object named as

Richard M Allman

11

0 references

Gregg C. Fonarow

object named as

Gregg C Fonarow

5

0 references

8

object named as

Javed Butler

1 reference

Europe PubMed Central

31 July 2017

Wilbert S Aronow

10

object named as

Wilbert S Aronow

1 reference

Europe PubMed Central

31 July 2017

Daniel E. Forman

9

object named as

Daniel E Forman

1 reference

Europe PubMed Central

31 July 2017

Prakash C Deedwania

4

object named as

Prakash Deedwania

1 reference

Europe PubMed Central

31 July 2017

Chakradhari Inampudi

1

object named as

Chakradhari Inampudi

1 reference

Europe PubMed Central

31 July 2017

Sridivya Parvataneni

2

object named as

Sridivya Parvataneni

1 reference

Europe PubMed Central

31 July 2017

Sumanth D Prabhu

7

object named as

Sumanth D Prabhu

1 reference

Europe PubMed Central

31 July 2017

language of work or name

0 references

publication date

18 April 2014

1 reference

Europe PubMed Central

31 July 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

31 July 2017

114

1 reference

Europe PubMed Central

31 July 2017

79-82

1 reference

Europe PubMed Central

31 July 2017

1

1 reference

Europe PubMed Central

31 July 2017

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169696

5 July 2018

Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169696

5 July 2018

Baseline characteristics, quality of care, and outcomes of younger and older Medicare beneficiaries hospitalized with heart failure: findings from the Alabama Heart Failure Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169696

5 July 2018

Rehospitalizations among patients in the Medicare fee-for-service program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169696

5 July 2018

Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169696

5 July 2018

Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169696

5 July 2018

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169696

5 July 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169696

5 July 2018

Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169696

28 October 2018

Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169696

28 October 2018

Eplerenone in patients with systolic heart failure and mild symptoms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169696

28 October 2018

Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4169696

28 October 2018

Underestimation of Risk Associations Due to Regression Dilution in Long-term Follow-up of Prospective Studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/24846806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use and side-effect profile of spironolactone in a private cardiologist's practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/24846806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update on Aldosterone Antagonists Use in Heart Failure With Reduced Left Ventricular Ejection Fraction Heart Failure Society of America Guidelines Committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/24846806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.AMJCARD.2014.03.062

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34216532&oldid=1866524827"